Skip to content

politics

Uncle Sam hitting a high striker with a large hammer. The high striker show a lambda at the top.

Cost-effectiveness thresholds under political pressure: where are the health economists?

The UK government is reportedly preparing to raise NICE’s cost-effectiveness threshold by 25%, as a bargaining chip to avoid US pharmaceutical tariffs. It’s time for health economists to reclaim this space and defend evidence-based decision-making.

Simon McNamara’s journal round-up for 21st January 2019

Every Monday our authors provide a round-up of some of the most recently published peer reviewed articles from the field. We don’t cover everything, or even what’s most important – just a few papers that have interested the author. Visit… Read More »Simon McNamara’s journal round-up for 21st January 2019